share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga Real-time News ·  Dec 23, 2022 01:36

Gainers

  • IsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday's regular session. Trading volume for IsoPlexis's stock is 33.5 million as of 12:30 EST. This is 80056.9% of its average full-day volume over the last 100 days. The company's market cap stands at $63.1 million.
  • Scopus BioPharma (NASDAQ:SCPS) shares moved upwards by 76.61% to $0.11. As of 12:30 EST, this security is trading at a volume of 293.1K shares, making up 30.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.
  • ORIC Pharmaceuticals (NASDAQ:ORIC) stock moved upwards by 55.56% to $4.67. The current volume of 25.5 million shares is 23562.9% of ORIC Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $184.7 million.
  • Baudax Bio (NASDAQ:BXRX) stock rose 29.64% to $2.93. As of 12:30 EST, Baudax Bio's stock is trading at a volume of 608.4K, which is 102.9% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 million.
  • Alvotech (NASDAQ:ALVO) shares rose 20.6% to $10.01. The current volume of 707.9K shares is 1579.8% of Alvotech's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.4 billion.
  • Mereo BioPharma Group (NASDAQ:MREO) shares moved upwards by 20.06% to $0.68. As of 12:30 EST, Mereo BioPharma Group's stock is trading at a volume of 467.9K, which is 95.4% of its average full-day volume over the last 100 days. The company's market cap stands at $84.9 million.

Losers

  • Lannett (NYSE:LCI) stock declined by 20.9% to $0.68 during Thursday's regular session. The current volume of 423.0K shares is 248.5% of Lannett's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $28.5 million.
  • Celyad Oncology (NASDAQ:CYAD) stock decreased by 20.4% to $0.57. The market value of their outstanding shares is at $12.9 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock decreased by 20.38% to $1.68. As of 12:30 EST, this security is trading at a volume of 942.7K shares, making up 175.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 million.
  • Immuron (NASDAQ:IMRN) shares decreased by 16.9% to $1.61. The market value of their outstanding shares is at $9.1 million.
  • Ambrx Biopharma (NYSE:AMAM) shares decreased by 16.27% to $1.64. As of 12:30 EST, this security is trading at a volume of 471.9K shares, making up 14.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $63.3 million.
  • Gossamer Bio (NASDAQ:GOSS) shares declined by 14.88% to $1.66. As of 12:30 EST, this security is trading at a volume of 2.6 million shares, making up 61.0% of its average full-day volume over the last 100 days. The company's market cap stands at $156.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment